Variantyx
Highly Engaged Employees
Highly Engaged EmployeesHealthcare Services · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1671 Worcester Rd Ste 400, Framingham, M...Phone Number
(617) 209-2090Website
www.variantyx.comRevenue
$42.3 MillionIndustry
ZI Rank: 9
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
8
4
4
5
15
9
About Variantyx
Variantyx is a molecular diagnostics company specializing in advanced whole-genome sequencing diagnostics for rare genetic disorders, reproductive genetics, and precision oncology. They offer a wide range of genetic tests, including targeted and comprehensive analyses, performed on a whole genome platform. Their innovative technology aims to improve diagnostic yield and shorten the diagnostic odyssey for patients. The company is dedicated to enhancing the quality of life for patients through state-of-the-art genomic tests and personalized medicine.Explore more
Variantyx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Variantyx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Variantyx had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Variantyx has new funding data
Check out if Variantyx is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Variantyx has recently received funding, and reach out quickly before it becomes old news!
Variantyx, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Variantyx recently announced quarterly report
Product Launch: Get notified when Variantyx launches new products
Congratulate Masked Content for being promoted to Masked Content at Variantyx
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Variantyx
Compare insights from companies similar to Variantyx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Variantyx is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Variantyx is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Variantyx.
Variantyx financials insights
Gather financial insights about Variantyx, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Series A
$3M
2019
Series B
$10M
2020
Debt
$350K
2021
Series C
$20M
2022
Other Financing Round
$41.5M
Debt
$20M
2024
Private Equity
$36M
Variantyx Tech Stack
A closer look at the technologies used by Variantyx
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Hiring Plans
Variantyx has more open roles in Operations than it has had at any time in the past 12 months.
Hiring Plans
Open Position
Variantyx News & Media
Variantyx Secures $36M Investment As Testing Demand And Market Share Continues To Increase
FRAMINGHAM, Mass.--(BUSINESS WIRE)--Variantyx, a leader in molecular diagnostics, announced today that it has secured an additional $36 million in funding from its portfolio of investors which includes Peregrine Ventures, Pitango HealthTech, New Era Capital Partners and Bosch Ventures. The company, a technology-driven provider of advanced genomic testing for genetic disorders, reproductive health and precision oncology markets has seen a rapid increase in test volumes in the first quarter of 20Expanded STR Detection Capability Enables Variantyx to Diagnose Additional Genetic Disorders
FRAMINGHAM, Mass.--(BUSINESS WIRE)--Variantyx, a leader in genomic precision medicine, today announced that the set of short tandem repeat (STR) expansions detected by its Genomic Unity® line of whole genome-based tests has been expanded. With these additions, Variantyx becomes one of the first laboratories to offer testing for two recently characterized ataxia variants: the biallelic AAGGG expansion in RFC1 that causes cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS) and tVariantyx Expands Its Reproductive Health Offerings with Launch of a Direct Replacement for Chromosomal Microarray Analysis
FRAMINGHAM, Mass.--(BUSINESS WIRE)--Variantyx, a leader in genomic precision medicine, today announced the launch of its IriSight™ CNV Analysis - a whole genome-based test for the detection of chromosomal abnormalities that correlate with clinical symptoms manifested in a fetus or a pregnancy, that may result in a genetic disorder or pregnancy loss. “IriSight™ CNV Analysis provides the first true alternative to CMA,” said Dr. Allan J. Fisher, FACOG, FACMG, Variantyx Medical Director. “Because tVariantyx Announces Additional Investment Enabling Rapid Expansion of Its Commercial Footprint
FRAMINGHAM, Mass.--(BUSINESS WIRE)--Variantyx, a leader in genomic precision medicine today, announced that it has secured additional funding from its portfolio of investors which includes Robert Bosch Venture Capital, Pitango HealthTech, New Era Capital Partners, 20/20 HealthCare Partners and Peregrine Ventures. The technology-driven provider of advanced genomic testing for genetic disorders, reproductive health and precision oncology markets continues to add many of the largest US healthcare
Read more news
Top Healthcare Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Variantyx
Sign Up For FreeTo access detailed company insights
Variantyx is a molecular diagnostics company specializing in advanced whole-genome sequencing diagnostics for rare genetic disorders, reproductive genetics, and precision oncology. They offer a wide range of genetic tests, including targeted and comprehensive analyses, performed on a whole genome platform. Their innovative technology aims to improv... Read More
